Clinical characteristics of platelet-mediated killing circulating parasite of major human malaria

References

• World Malaria Report 2021. Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2021. https://www.who.int/publications/i/item/9789240040496
   Google Scholar
• Rochford R, Kazura J. Introduction: immunity to malaria. Immunol Rev. 2020;293(1):1–10.
   Web of Science ®Google Scholar
• Gazzinelli RT, Kalantari P, Fitzgerald KA, et al. Innate sensing of malaria parasites. Nat Rev Immunol. 2014;14(11):744–757.
   PubMed Web of Science ®Google Scholar
• Cowman AF, Healer J, Marapana D, et al. Malaria: biology and disease. Cell. 2016;167(3):610–624.
   PubMed Web of Science ®Google Scholar
• Barber BE, William T, Grigg MJ, et al. Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria. PLoS Pathog. 2015;11(1):e1004558.
   PubMed Web of Science ®Google Scholar
• Barber BE, Grigg MJ, William T, et al. Effects of aging on parasite biomass, inflammation, endothelial activation, microvascular dysfunction and disease severity in Plasmodium knowlesi and Plasmodium falciparum malaria. J Infect Dis. 2017;215(12):1908–1917.
   PubMed Web of Science ®Google Scholar
• Yeo TW, Lampah DA, Gitawati R, et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A. 2008;105(44):17097–17102.
   PubMed Web of Science ®Google Scholar
• Masukume G. Thrombocytopenia: important in diagnosing imported malaria. BMJ. 2013;346:f3720.
   PubMedGoogle Scholar
• Kho S, Barber BE, Johar E, et al. Platelets kill circulating parasites of all major Plasmodium species in human malaria. Blood. 2018;132(12):1332–1344.
   PubMed Web of Science ®Google Scholar
• Gebreweld A, Erkihun Y, Feleke DG, et al. Thrombocytopenia as a diagnostic marker for malaria in patients with acute febrile illness. J Trop Med. 2021;2021:5585272.
   PubMedGoogle Scholar
• O'Sullivan JM, O'Donnell JS. Platelets in malaria pathogenesis. Blood. 2018;132:1222–1224.
   PubMed Web of Science ®Google Scholar
• Mather MW, Ke H. Novel defense peptides from platelets kill malaria parasites. Trends Parasitol. 2018;34(9):729–731.
   PubMed Web of Science ®Google Scholar
• Morrell CN, Aggrey AA, Chapman LM, et al. Emerging roles for platelets as immune and inflammatory cells. Blood. 2014;123(18):2759–2767.
   PubMed Web of Science ®Google Scholar
• Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011;11(4):264–274.
   PubMed Web of Science ®Google Scholar
• Aquino-Dominguez AS, Romero-Tlalolini M, Torres-Aguilar H, et al. Recent advances in the discovery and function of antimicrobial molecules in platelets. Int J Mol Sci. 2021;22(19):10230.
   PubMed Web of Science ®Google Scholar
• Ali RA, Wuescher LM, Dona KR, et al. Platelets mediate host defense against Staphylococcus aureus through direct bactericidal activity and by enhancing macrophage activities. J Immunol. 2017;198(1):344–351.
   PubMed Web of Science ®Google Scholar
• Liu E, Chen Y, Xu J, et al. Platelets inhibit methicillin-resistant Staphylococcus aureus by inducing hydroxyl radical-mediated apoptosis-like cell death. Microbiol Spectr. 2022;10(4):e0244121.
   PubMed Web of Science ®Google Scholar
• Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007;13(4):463–469.
   PubMed Web of Science ®Google Scholar
• Wong CHY, Jenne CN, Petri B, et al. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol. 2013;14(8):785–792.
   PubMed Web of Science ®Google Scholar
• McMorran BJ, Wieczorski L, Drysdale KE, et al. Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum. Science. 2012;338(6112):1348–1351.
   PubMed Web of Science ®Google Scholar
• Gai PP, van Loon W, Siegert K, et al. Duffy antigen receptor for chemokines gene polymorphisms and malaria in Mangaluru, India. Malaria J. 2019;18(1):328.
   PubMed Web of Science ®Google Scholar
• Love MS, Millholland MG, Mishra S, et al. Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials. Cell Host Microbe. 2012;12(6):815–823.
   PubMed Web of Science ®Google Scholar
• McMorran BJ, Marshall VM, de Graaf C, et al. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science. 2009;323(5915):797–800.
   PubMed Web of Science ®Google Scholar
• Tovar-Acero C, Velasco MC, Avilés-Vergara PA, et al. Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian northwest region. Parasite Epidemiol Control. 2021;13:e203.
   Google Scholar
• Dos-Santos J, Silva-Filho JL, Judice CC, et al. Platelet disturbances correlate with endothelial cell activation in uncomplicated Plasmodium vivax malaria. PLoS Negl Trop Dis. 2020;14(7):e0007656.
   PubMed Web of Science ®Google Scholar
• Hawadak J, Dongang Nana RR, Singh V. Epidemiological, physiological and diagnostic comparison of Plasmodium ovale curtisi and Plasmodium ovale wallikeri. Diagnostics. 2021;11(10):1900.
   Web of Science ®Google Scholar
• Hsieh F, Turner L, Bolla JR, et al. The structural basis for CD36 binding by the malaria parasite. Nat Commun. 2016;7(1):12837.
   PubMedGoogle Scholar
• Gruszczyk J, Huang RK, Chan L, et al. Cryo-EM structure of an essential Plasmodium vivax invasion complex. Nature. 2018;559(7712):135–139.
   PubMed Web of Science ®Google Scholar
• Hermand P, Gane P, Huet M, et al. Red cell ICAM-4 is a novel ligand for platelet-activated αIIbβ3 integrin. J Biol Chem. 2003;278(7):4892–4898.
   PubMed Web of Science ®Google Scholar
• Ndunge OBA, Kilian N, Salman MM. Cerebral malaria and neuronal implications of Plasmodium falciparum infection: from mechanisms to advanced models. Adv Sci. 2022;9(36):e2202944.
   Web of Science ®Google Scholar
• WHO Guidelines for Malaria. WHO/UCN/GMP/2022.01. License: CC BY-NC-SA 3.0 IGO [cited 2022 Feb 18]. Geneva: World Health Organization; 2022.
   Google Scholar
• Van der Pluijm RW, Tripura R, Hoglund RM, et al. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet. 2020;395(10233):1345–1360.
   PubMed Web of Science ®Google Scholar
• Wakoli DM, Ondigo BN, Ochora DO, et al. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs. BMC Med. 2022;20(1):448.
   PubMed Web of Science ®Google Scholar
• Kagoro FM, Barnes KI, Marsh K, et al. Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis. Lancet Microbe. 2022;3(3):e184–e192.
   PubMedGoogle Scholar
• Salman MM, Al-Obaidi Z, Kitchen P, et al. Advances in applying computer-aided drug design for neurodegenerative diseases. Int J Mol Sci. 2021;22(9):4688.
   PubMed Web of Science ®Google Scholar
• Aldewachi H, Al-Zidan RN, Conner MT, et al. High-throughput screening platforms in the discovery of novel drugs for neurodegenerative diseases. Bioengineering. 2021;8(2):30.
   PubMed Web of Science ®Google Scholar
• Wagner K, Unger L, Salman MM, et al. Signaling mechanisms and pharmacological modulators governing diverse aquaporin functions in human health and disease. Int J Mol Sci. 2022;23(3):1388.
   PubMed Web of Science ®Google Scholar
• Markou A, Unger L, Abir-Awan M, et al. Molecular mechanisms governing aquaporin relocalisation. Biochim Biophys Acta Biomembr. 2022;1864(4):183853.
   PubMed Web of Science ®Google Scholar